Bank Of America Corp Applied Genetic Technologies Corp Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $191 - $586	-659 Reduced 4.37%	14,420 $4,000
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $9,348 - $16,586	-15,079 Reduced 50.0%	15,079 $11,000
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $3,528 - $8,937	-3,298 Reduced 9.86%	30,158 $32,000
Q4 2021 Feb 08, 2022	BUY	$1.87 - $2.91 $10,198 - $15,871	5,454 Added 19.48%	33,456 $64,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $120,105 - $164,396	-39,902 Reduced 58.76%	28,002 $84,000
Q2 2021 Sep 13, 2021	BUY	$3.62 - $5.23 $245,812 - $355,137	67,904 New	67,904 $265,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.